YOLFTbeta
30

Sichuan Goldstone Orient New Material Equipment Co Ltd

300434 · SHE · Industrials / Industrial Distribution

11.84CNY-0.71 (-5.66%)

Price History

Full chart

Market Stats

Previous Close12.55
Open12.40
Day Range11.75 – 12.59
52-Week Range8.58 – 13.82
Volume24.28M
Market Cap5.19B
P/E (TTM)32.30
Forward P/E0.00
EPS0.40
Dividend Yield0.63%
Beta0.51
50-Day Avg11.36
200-Day Avg10.75

About

Sichuan Goldstone Asia Pharmaceutical Inc. engages in the research, development, and sale of medicines and health products in China. The company offers over-the-counter drugs, prescription drugs, and health food/health supplements, as well as Chinese herbal active pharmaceutical ingredients and food addictives, and medical devices. It produces and sells plastic composite pipes, pipe fittings and equipment, as well as develops vacuum coating, industrial machinery, pipe fitting molds, construction equipment, and special equipment. The company produces, installs, and maintains special equipment. It also imports and exports spare parts, raw, and auxiliary materials. Sichuan Goldstone Asia Pharmaceutical Inc. was founded in 1962 and is based in Hangzhou, China.

Company Details

  • SectorIndustrials
  • IndustryIndustrial Distribution
  • CEOMr. Yiping Ma
  • Employees1.79K
  • HeadquartersNo. 4760 Jiangnan Avenue, Hangzhou, China, 610200, China
  • Websitehttps://www.goldstone-group.com

Leadership

  • Mr. Yiping MaChairman & GM · b. 1971
  • Mr. Qing Guo WangCFO & Accounting Supervisor · b. 1975
  • Mr. Qiang LinDeputy GM, Secretary of the Board & Director · b. 1964
  • Ms. Xiaoxia ShengDeputy GM & Director · b. 1977
  • Mr. Zhihao WangDeputy General Manager · b. 1974

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue231.34M264.18M238.59M172.83M117.11M162.41M704.01M970.72M1.01B777.30M1.05B1.24B1.21B1.10B1.04B
Growth (%)-+14.20%-9.69%-27.56%-32.24%+38.68%+333.47%+37.88%+3.59%-22.70%+35.53%+17.95%-2.69%-8.84%-5.80%
Cost of Revenue134.82M159.50M149.74M104.50M71.15M106.23M253.88M330.87M358.14M359.85M459.56M480.74M467.99M473.18M433.16M
Gross Profit96.52M104.68M88.84M68.33M45.96M56.18M450.13M639.84M647.47M417.45M593.94M761.87M741.21M629.17M605.23M
Gross Margin41.72%39.63%37.24%39.54%39.25%34.59%63.94%65.91%64.39%53.71%56.38%61.31%61.30%57.08%58.29%
Operating Expense33.99M38.88M35.39M31.67M25.19M32.20M298.97M450.57M486.90M1.09B504.96M469.90M563.27M498.70M448.95M
Operating Income62.54M65.80M53.45M36.66M20.77M23.98M151.16M189.28M160.57M-667.94M88.98M291.97M177.94M130.47M156.29M
Operating Margin27.03%24.91%22.40%21.21%17.74%14.77%21.47%19.50%15.97%-85.93%8.45%23.50%14.72%11.84%15.05%
EBITDA60.37M68.53M59.14M39.63M31.56M32.94M209.08M271.79M242.70M-578.85M180.51M382.06M273.99M226.14M257.40M
EBITDA Margin26.09%25.94%24.79%22.93%26.95%20.28%29.70%28.00%24.13%-74.47%17.13%30.75%22.66%20.51%24.79%
Net Income53.97M56.86M48.90M32.11M23.38M25.53M116.11M149.15M120.33M-687.66M66.48M218.79M126.20M91.76M131.62M
Net Income Margin23.33%21.52%20.50%18.58%19.96%15.72%16.49%15.37%11.97%-88.47%6.31%17.61%10.44%8.32%12.68%
R&D-12.99M12.08M9.72M8.82M10.38M21.09M27.92M28.54M27.84M37.45M39.18M50.01M50.00M55.03M
R&D as % of Total Revenue-4.92%5.06%5.63%7.53%6.39%3.00%2.88%2.84%3.58%3.55%3.15%4.14%4.54%5.30%
Interest Expense99.73K291.10K27.10K35.92K33.53K43.92K10.45M2.64M1.12M315.62K197.13K625.43K3.25M1.48M1.16M
Interest Expense % of Total Revenue0.04%0.11%0.01%0.02%0.03%0.03%1.48%0.27%0.11%0.04%0.02%0.05%0.27%0.13%0.11%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets281.59M286.51M278.13M287.26M432.43M483.79M3.13B3.19B3.23B2.49B2.77B3.06B3.10B3.05B3.23B
Total Liabilities175.94M124.00M78.45M65.67M48.72M80.73M574.95M508.31M456.41M435.23M606.12M756.56M677.37M585.32M651.42M
Total Equity105.65M162.51M199.68M221.59M383.70M402.43M2.52B2.64B2.73B2.02B2.08B2.27B2.40B2.45B2.55B
Cash80.11M95.83M120.83M116.89M202.81M68.95M192.78M342.72M337.77M410.76M235.43M440.31M545.90M417.29M307.32M
Total Debt14.00M-----73.00M25.00M8.00M10.00M980.16K10.31M113.33M76.16M-
Net Debt-66.11M-95.83M-120.83M-116.89M-202.81M-68.95M-119.78M-317.72M-329.77M-400.76M-234.45M-429.99M-431.07M-341.14M-

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow52.68M36.47M39.93M26.20M30.81M25.16M172.82M199.08M186.47M132.99M136.40M323.04M151.14M158.15M207.89M
Investing Cash Flow-18.83M-6.48M-5.38M-19.66M-91.64M-161.15M-756.66M25.94M-138.80M-28.88M-265.61M-61.16M-140.50M-216.76M-
Financing Cash Flow-28.62M-14.27M-9.55M-10.48M138.62M5.40M710.01M-74.85M-52.27M-28.58M-46.61M-61.86M98.57M-70.63M-
Capital Expenditure12.50M6.48M5.39M20.16M27.82M85.71M32.68M26.75M27.20M35.08M85.36M54.15M66.10M72.92M99.57M
Free Cash Flow40.18M29.99M34.54M6.04M2.99M-60.55M140.14M172.33M159.27M97.91M51.03M268.89M85.04M85.23M108.32M
Dividends Paid78.82M270.33K9.55M10.48M10.57M6.80M16.57M26.85M32.14M27.57M325.35K113.06K741.08K45.21M28.65M
FCF to OCF76.27%82.24%86.51%23.06%9.71%-240.70%81.09%86.56%85.41%73.62%37.41%83.24%56.27%53.89%52.11%
Dividend Paid to FCF196.17%0.90%27.64%173.54%353.45%-11.23%11.82%15.58%20.18%28.16%0.64%0.04%0.87%53.04%26.45%

Earnings

Report DateJun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 25, 2016Oct 26, 2016Feb 27, 2017Apr 26, 2017Aug 28, 2017Oct 26, 2017Dec 31, 2017Apr 19, 2018Aug 24, 2018Oct 25, 2018Dec 31, 2018Apr 26, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 29, 2020Aug 26, 2020Oct 29, 2020Dec 31, 2020Apr 26, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023May 24, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 23, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------------------------
EPS Actual0.020.010.020.010.040.010.04-0.020.080.040.210.120.000.040.210.13-0.000.040.130.05-0.04-0.25-1.470.20-0.010.02-0.040.170.040.060.280.360.03-0.04-0.030.22-0.130.050.080.160.010.080.090.29-0.05
Surprise---------------------------------------------
Timing----After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hours-After-hoursPre-marketPre-market-Pre-market-------------------After-hours---After-hours-----

Key Statistics & Ratios

Market Cap5.19B
Enterprise Value4.68B
Trailing P/E32.30
Forward P/E0.00
Price / Sales5.00
Price / Book1.93
EPS0.40
Book Value6.51
Revenue (TTM)1.04B
Gross Profit (TTM)619.65M
EBITDA257.69M
Profit Margin15.56%
Operating Margin-13.93%
Return on Equity6.18%
Return on Assets3.35%
Shares Outstanding401.74M
Shares Float209.18M
Beta0.51
Dividend Yield0.63%
Dividend Rate0.08
Payout Ratio20.41%

Dividends

20261×
0.08Jun 17, 2026
20251×
0.07Jun 19, 2025
20241×
0.11Jun 28, 2024
20201×
0.07Aug 11, 2020
20191×
0.08Jun 27, 2019
20181×
0.06Jul 17, 2018
20171×
0.03May 10, 2017
20161×
0.03Jun 17, 2016

Stock Splits

  • Oct 12, 20181.8:1
  • Jun 17, 201620:10